Phlebolith in Urinary Bladder: No Treatment Required
A phlebolith in the urinary bladder is a diagnostic misunderstanding—phleboliths are calcified thrombi in pelvic veins, not bladder pathology, and require no treatment. They are incidental findings that must be distinguished from actual bladder stones or ureteral calculi.
Understanding Phleboliths vs. Bladder Pathology
Phleboliths are benign calcified thrombi located in pelvic vasculature, not within the urinary tract itself. They appear on imaging due to their proximity to the bladder and distal ureters, but they are extraluminal vascular structures 1, 2.
- Phleboliths occur at frequencies equal to or greater than ureteral stones on CT imaging, making them extremely common incidental findings 2
- On thin-slice CT, 60% of phleboliths demonstrate central lucency with 100% specificity for distinguishing them from stones 1
- 97% of phleboliths show round contour on thin-slice CT with 93% specificity 1
- The "comet tail sign" (irregular tapering soft tissue mass) suggests phlebolith etiology, while the "rim sign" (circumferential ureteral soft tissue edema) suggests ureteral stone 2
When Symptoms Are Present: Evaluate for True Urologic Pathology
If the patient has hematuria, dysuria, or obstructive symptoms, these symptoms are NOT caused by phleboliths and require evaluation for actual bladder or urinary tract disease 3, 4.
For Gross Hematuria:
- Urgent urologic evaluation with cystoscopy and upper tract imaging (CT urography) is mandatory regardless of whether bleeding is self-limited, as gross hematuria carries a 30-40% malignancy risk 4
- Bladder stones due to BPH occur in only 3.4% of BPH patients versus 0.4% in controls, and when present require surgical removal with medical BPH management 3
- Gross hematuria must be proven to be of prostatic etiology through appropriate evaluation before attributing it to BPH 3, 5
For Dysuria Without Infection:
- Dysuria results from bladder muscle contraction and inflamed urethral mucosa, with urinary tract infection being the most common cause 6
- When urine culture is sterile, consider non-infectious causes including eosinophilic cystitis, interstitial cystitis, or bladder malignancy 6, 7
- Cystoscopy with biopsy may be required for persistent dysuria with negative cultures 3, 7
For Obstructive Symptoms:
- Evaluate for BPH with digital rectal examination, symptom assessment (I-PSS), and urinalysis 3
- Surgery is recommended for refractory urinary retention, recurrent UTIs, recurrent gross hematuria, bladder stones, or renal insufficiency clearly due to BPH 3
- Alpha-blockers (tamsulosin, alfuzosin) are first-line for LUTS, while 5-alpha reductase inhibitors (finasteride, dutasteride) are effective for LUTS with gland enlargement 3, 5
Critical Diagnostic Pitfall
The most important clinical error is attributing urinary symptoms to an incidental phlebolith seen on imaging. Phleboliths are vascular calcifications outside the urinary tract and cannot cause dysuria, hematuria, or obstruction 1, 2, 8.
- On routine unenhanced CT with 5mm collimation, 99% of phleboliths fail to reveal a radiolucent center despite appearing to have one on plain radiography 8
- The close proximity of distal ureters to pelvic vasculature causes diagnostic confusion, but clinical correlation with symptoms of ureteral obstruction (flank pain, hydronephrosis) distinguishes true stones from phleboliths 2
- If a pelvic calcification is truly within the bladder lumen (not pelvic vasculature), it is a bladder stone requiring surgical removal, not a phlebolith 3
Appropriate Management Algorithm
Confirm the calcification is actually a phlebolith (extraluminal vascular calcification) versus bladder stone (intraluminal) using thin-slice CT with characteristic findings of central lucency and round contour 1
If truly a phlebolith: No treatment or follow-up required 1, 2
If symptoms are present: Investigate for actual urologic pathology
If bladder stone is confirmed (not phlebolith): Surgical removal with treatment of underlying cause (typically BPH) 3